Compromise of the pulmonary endothelial cell (EC) barrier is induced by mechanical stress which is associated with ventilator-induced lung injury (VILI), This process leads to increased vascular permeability, alveolar flooding, leukocyte infiltration, hypoxemia, and increased morbidity and mortality. Project #3 scientists have previously identified cytoskeletal mechanisms of EC barrier regulation by barrier-protective strategies (oxidized phosphocholine, sphingosine 1-phosphate, physiologic shear stress and cyclic stretch (CS) and barrier-disruptive mechanical and chemical stimuli (thrombin, pathologic CS). In addition, these PPG investigator have described the critical involvement of small GTPases Rac and Rho in remodeling of EC cytoskeleton and cell contacts essential for EC barrier regulation. Our published results and preliminary data strongly suggest that magnitude-dependent modulation of Rac and Rho activities by CS significantly impacts agonist-induced EC permeability changes. The Project #3 hypothesis is that pathologic CS and vascular endothelial growth factor (VEGF), known to be elevated during VILI, promote lung endothelial barrier dysfunction via synergistic effects on Rho pathway-mediated EC permeability. These processes are counterbalanced by Rac-dependent mechanisms induced by barrier-protective stimuli such as hepatocyte growth factor (HGF) and physiologic stretch. We speculate that focal adhesions may act as mechanosensors and modulate small GTPase activities via specific paxillin interactions with Rac and Rho protein regulators.
Specific Aim #1 will study synergistic effects between pathologic CS and VEGF on activation of Rhomediated EC barrier dysfunction.
Specific Aim #2 will define barrier-protective strategies in amelioration of VILI-associated EC barrier dysfunction via changes in a balance between the Rho and Rac activities.
Specific Aim #3 will study novel mechanisms of Rac/Rho regulation by mechanochemical factors via interactions between wild type paxillin (or/and paxillin containing the Gly73Ser polymorphism) interactions with modulators of Rac and Rho activity (GIT2, betaPIX, PAK1 and p190RhoGAP). These studies will uncover novel molecular mechanisms involved in the pathogenesis and resolution of ventilator-induced lung injury.
|Wang, X; Bleher, R; Wang, L et al. (2017) Imatinib Alters Agonists-mediated Cytoskeletal Biomechanics in Lung Endothelium. Sci Rep 7:14152|
|Shekhawat, Gajendra S; Dudek, Steven M; Dravid, Vinayak P (2017) Development of ultrasound bioprobe for biological imaging. Sci Adv 3:e1701176|
|Camp, Sara M; Chiang, Eddie T; Sun, Chaode et al. (2016) ""Pulmonary Endothelial Cell Barrier Enhancement by Novel FTY720 Analogs: Methoxy-FTY720, Fluoro-FTY720, and ?-Glucuronide-FTY720"". Chem Phys Lipids 194:85-93|
|de la Vega, Montserrat Rojo; Dodson, Matthew; Gross, Christine et al. (2016) Role of Nrf2 and Autophagy in Acute Lung Injury. Curr Pharmacol Rep 2:91-101|
|Tao, Shasha; Rojo de la Vega, Montserrat; Quijada, Hector et al. (2016) Bixin protects mice against ventilation-induced lung injury in an NRF2-dependent manner. Sci Rep 6:18760|
|Viswanathan, P; Ephstein, Y; Garcia, J G N et al. (2016) Differential elastic responses to barrier-altering agonists in two types of human lung endothelium. Biochem Biophys Res Commun 478:599-605|
|Fu, Panfeng; Usatyuk, Peter V; Lele, Abhishek et al. (2015) c-Abl mediated tyrosine phosphorylation of paxillin regulates LPS-induced endothelial dysfunction and lung injury. Am J Physiol Lung Cell Mol Physiol 308:L1025-38|
|Choi, Sangwook; Camp, Sara M; Dan, Arkaprava et al. (2015) A genetic variant of cortactin linked to acute lung injury impairs lamellipodia dynamics and endothelial wound healing. Am J Physiol Lung Cell Mol Physiol 309:L983-94|
|Camp, Sara M; Chiang, Eddie T; Sun, Chaode et al. (2015) Pulmonary endothelial cell barrier enhancement by novel FTY720 analogs: methoxy-FTY720, fluoro-FTY720, and ?-glucuronide-FTY720. Chem Phys Lipids 191:16-24|
|Shen, Kui; Ramirez, Benjamin; Mapes, Brandon et al. (2015) Structure-Function Analysis of the Non-Muscle Myosin Light Chain Kinase (nmMLCK) Isoform by NMR Spectroscopy and Molecular Modeling: Influence of MYLK Variants. PLoS One 10:e0130515|
Showing the most recent 10 out of 248 publications